Results 231 to 240 of about 355,709 (346)

METH-2 silencing and promoter hypermethylation in NSCLC [PDF]

, 2004
J R Dunn, D. Panutsopulos, Michael W. Shaw, Jim Heighway, R Dormer, Emil Salmo, S G Watson, John K. Field, Triantafillos Liloglou   +8 more
openalex   +1 more source

The potential role of PIWI-interacting RNAs in non-small cell lung cancer. [PDF]

Front Oncol
Song L, Zhou JG, Ma H.
europepmc   +1 more source

USP28 Promotes Osimertinib Resistance in H1975 NSCLC Cells by Deubiquitinating and Stabilizing SIRT1

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Osimertinib (OSI) resistance in non‐small cell lung cancer (NSCLC) remains a significant challenge. This report explored the precise role of USP28 on OSI resistance in NSCLC and identified a functional downstream effector. OSI‐resistant H1975 cells (H1975/OSI) were established by long‐term OSI exposure.
Hu‐Sen Fan, Xiu‐Mei Li, Jia‐Qi Gu, Hai‐Feng Wang, Zhen‐Jiang Zhang   +4 more
wiley   +1 more source

Is a Standard Therapy Against IIIA N2 NSCLC Induction Chemotherapy Plus Surgery?

, 2002
Nobuyuki Yamamoto, Gyo Asai, M. Ebisawa, Masahiro Endo, Toshiaki Takahashi   +4 more
openalex   +2 more sources

Hsa_circ_0075451 promotes NSCLC proliferation, metastasis, and glycolysis through interaction with the RNA-binding protein RBM4. [PDF]

Discov Oncol
Su C, Wang Y, Shi K, Bai Z, Yu D, Liu Z.
europepmc   +1 more source

Impact of Baseline Nutritional Status, Psychological Health, Fatigue, and Insomnia on Outcomes of Immune Checkpoint Inhibitors in Advanced Non‐Small Cell Lung Cancer: A Retrospective Cohort Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigated the impact of pretreatment nutritional status, psychological health, fatigue, and insomnia on outcomes of immune checkpoint inhibitors (ICIs) monotherapy in patients with advanced non‐small cell lung cancer (NSCLC). A total of 80 patients with stage IV NSCLC were enrolled.
Yu‐Xuan Zhu, Yuan‐Yuan Zhang, Xiu‐Juan Jiang   +2 more
wiley   +1 more source

Advances in radiological staging of non-small cell lung cancer (NSCLC) [PDF]

, 2004
S. Rankin
openalex   +1 more source

Early detection of non-small cell lung cancer: an electronic health record data-driven approach. [PDF]

BMC Med
Li X, Yuan EY, Kuperberg SJ, Bonzel CL, Jeffway MI, Cai T, Liao KP, Aguiar-Ibáñez R, Kao YH, Santorelli ML, Christiani DC, Cai T, Duan R.   +12 more
europepmc   +1 more source

RBM15 Mediated m6A Modification of SRSF1 Inhibits Cuproptosis in Non‐Small Cell Lung Cancer by Mediating ATP7B Alternative Splicing

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Inhibition of cuproptosis contributes to the development of non‐small cell lung cancer (NSCLC). The expression of RNA‐binding motif protein 15 (RBM15) is upregulated in NSCLC. Nonetheless, its relationship with cuproptosis remains unclear. This study aimed to explore the role of RBM15 in regulating cuproptosis in NSCLC. A549 cells were treated
Shan‐shan Mao, Dong‐yu Wu, Rong‐hua Cui, Xiao‐zhen Cheng   +3 more
wiley   +1 more source

Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study

, 2003
Maria Werner‐Wasik, Charles Scott, Benjamin Movsas, Corey J. Langer, Linda Sarna, N. Nicolaou, Ritsuko Komaki, Mitchell Machtay, Colum J Smith, R. Axelrod, Roger W. Byhardt   +10 more
openalex   +1 more source